Medroxyprogesterone acetate treatment of abnormal uterine bleeding: factors predicting satisfaction.

OBJECTIVE This study was undertaken to identify the determinants of patient satisfaction with a cyclic regimen of medroxyprogesterone acetate (MPA) for abnormal uterine bleeding. STUDY DESIGN A prospective cohort study of 413 premenopausal women were treated for 3 to 5 months with oral MPA 10 to 20 mg per day for 10 to 14 days per month. We assessed satisfaction with and willingness to continue MPA. Baseline characteristics hypothesized to predict treatment satisfaction were entered into logistic regression analysis. RESULTS Sixty-five percent of subjects (271) completed at least 3 months of MPA, 79% (215) filled out a satisfaction survey, and 57% (123) expressed satisfaction with MPA. Satisfaction was predicted by age 35 years or older (odds ratio [OR] 2.67, CI 1.07-6.7), desire for uterine conservation (OR 1.36, CI 1.11-1.66), perceived importance of stopping bleeding (OR 0.69, CI 0.54-0.87), and tubal sterilization (OR 0.52, CI 0.28-0.96). Neither bleeding history nor parity predicted MPA satisfaction. CONCLUSION These findings underscore the importance of considering patient age, fertility status, attitudes about uterine conservation, and desire for definitive resolution of bleeding when deciding whether to use MPA versus other treatments for abnormal uterine bleeding.

[1]  S. Mulaik.  Foundations of Factor Analysis , 2009 .

[2]  C. Steiner,et al.  Hysterectomy Rates in the United States 1990–1997 , 2002, Obstetrics and gynecology.

[3]  L. Ackerson,et al.  Outcomes After Rollerball Endometrial Ablation for Menorrhagia , 2001, Obstetrics and gynecology.

[4]  S. Bernstein,et al.  Differences in menstrual bleeding characteristics, functional status, and attitudes toward menstruation in three groups of women. , 1999, Journal of women's health & gender-based medicine.

[5]  A. Kaunitz.  Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. , 1998, International journal of fertility and women's medicine.

[6]  M. Charlson,et al.  Patients' expectations and satisfaction with total hip arthroplasty. , 1997, The Journal of arthroplasty.

[7]  P. Brenner,et al.  Management of abnormal uterine bleeding. , 1996, American journal of obstetrics and gynecology.

[8]  P. Lumbiganon,et al.  Protective effect of depot‐medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case‐control study , 1996, British journal of obstetrics and gynaecology.

[9]  J. Dale,et al.  Patient expectations: what do primary care patients want from the GP and how far does meeting expectations affect patient satisfaction? , 1995, Family practice.

[10]  A. Coulter,et al.  Quality of life and patient satisfaction following treatment for menorrhagia. , 1994, Family practice.

[11]  P. Warner.  Preferences regarding treatments for period problems: relationship to menstrual and demographic factors. , 1994, Journal of psychosomatic obstetrics and gynaecology.

[12]  K. Carlson,et al.  The Maine Women's Health Study: II. Outcomes of Nonsurgical Management of Leiomyomas, Abnormal Bleeding, and Chronic Pelvic Pain , 1994, Obstetrics and gynecology.

[13]  T. Toth,et al.  Abnormal uterine bleeding in the perimenopause. , 1993, International journal of fertility and menopausal studies.

[14]  E. McGlynn,et al.  The Appropriateness of Hysterectomy: A Comparison of Care in Seven Health Plans , 1993 .

[15]  R. Valle.  Endometrial ablation for dysfunctional uterine bleeding: Role of GnRH agonists , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[16]  I. Fraser,et al.  Treatment of Ovulatory and Anovulatory Dysfunctional Uterine Bleeding with Oral Progestogens , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.

[17]  Field Cs.  Dysfunctional uterine bleeding. , 1988, Primary care.